Explore

Trendline Trendline
Longeveron Reports Q1 2026 Financial Results and Strategic Developments in Stem Cell Therapy

Longeveron Reports Q1 2026 Financial Results and Strategic Developments in Stem Cell Therapy

Longeveron Reports Q1 2026 Financial Results and Strategic Developments in Stem Cell Therapy
Trendline Trendline
Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates

Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates

Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates
Trendline Trendline
Anteris Technologies Reports Q1 2026 Financial Results with Revenue Decline

Anteris Technologies Reports Q1 2026 Financial Results with Revenue Decline

Anteris Technologies Reports Q1 2026 Financial Results with Revenue Decline
Trendline Trendline
Cabaletta Bio Reports Increased Net Loss in Q1 2026 Amid Ongoing Clinical Developments

Cabaletta Bio Reports Increased Net Loss in Q1 2026 Amid Ongoing Clinical Developments

Cabaletta Bio Reports Increased Net Loss in Q1 2026 Amid Ongoing Clinical Developments
Trendline Trendline
Palatin Technologies Reports Q3 2026 Financial Results and Business Progress

Palatin Technologies Reports Q3 2026 Financial Results and Business Progress

Palatin Technologies Reports Q3 2026 Financial Results and Business Progress
Trendline Trendline
Edesa Biotech Reports Increased Net Loss Amid R and Manufacturing Expansion

Edesa Biotech Reports Increased Net Loss Amid R and Manufacturing Expansion

Edesa Biotech Reports Increased Net Loss Amid R and Manufacturing Expansion
Trendline Trendline
Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026

Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026

Atara Biotherapeutics Reports Significant Revenue Decline and Operational Updates for Q1 2026
Trendline Trendline
Lucid Diagnostics Reports First Quarter 2026 Financial Results Highlighting Revenue Growth and Strategic Initiatives

Lucid Diagnostics Reports First Quarter 2026 Financial Results Highlighting Revenue Growth and Strategic Initiatives

Lucid Diagnostics Reports First Quarter 2026 Financial Results Highlighting Revenue Growth and Strategic Initiatives
Trendline Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Trendline Trendline
Adagio Medical Reports Q1 2026 Financial Results and Clinical Progress

Adagio Medical Reports Q1 2026 Financial Results and Clinical Progress

Adagio Medical Reports Q1 2026 Financial Results and Clinical Progress
Trendline Trendline
Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates

Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates

Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates
Trendline Trendline
Adagio Medical Reports Q1 2026 Financial Results and Advances in Cardiac Arrhythmia Treatment

Adagio Medical Reports Q1 2026 Financial Results and Advances in Cardiac Arrhythmia Treatment

Adagio Medical Reports Q1 2026 Financial Results and Advances in Cardiac Arrhythmia Treatment